Jim Johnson

ID: 1b8379ff-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA Shuts Down OTC Drug Manufacturer with Longstanding and Pervasive cGMP and Labeling Issues

Focus on Regulation · October 25, 2018

FDA publishes internal policy on prioritizing surveillance inspections for drug manufacturing sites

Focus on Regulation · September 5, 2018

CFDA Continues to Expand Oversea Inspection

Focus on Regulation · March 12, 2018

The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns

Focus on Regulation · January 5, 2018

FDA Issues New Guidance Documents on Regenerative Medicine but Delays Enforcement

Focus on Regulation · November 17, 2017